Transdermal delivery of erythromycin lactobionate-implications for the therapy of gastroparesis Academic Article uri icon

Overview

MeSH Major

  • Anti-Bacterial Agents
  • Erythromycin
  • Skin Absorption

abstract

  • Erythromycin lactobionate, when administered transdermally, can be delivered at levels sufficient to treat gastroparesis. This technique warrants in vivo investigation.

publication date

  • July 22, 1997

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9218087

Additional Document Info

start page

  • 589

end page

  • 92

volume

  • 11

number

  • 3